BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burke CA, Dekker E, Samadder NJ, Stoffel E, Cohen A. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial. BMC Gastroenterol 2016;16:87. [PMID: 27480131 DOI: 10.1186/s12876-016-0494-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Wierzbicki J, Lipiński A, Bednarz-Misa I, Lewandowski Ł, Neubauer K, Lewandowska P, Krzystek-Korpacka M. Monocyte Chemotactic Proteins (MCP) in Colorectal Adenomas Are Differently Expressed at the Transcriptional and Protein Levels: Implications for Colorectal Cancer Prevention. J Clin Med 2021;10:5559. [PMID: 34884259 DOI: 10.3390/jcm10235559] [Reference Citation Analysis]
2 Kim HI, Schultz CR, Buras AL, Friedman E, Fedorko A, Seamon L, Chandramouli GVR, Maxwell GL, Bachmann AS, Risinger JI. Ornithine decarboxylase as a therapeutic target for endometrial cancer. PLoS One 2017;12:e0189044. [PMID: 29240775 DOI: 10.1371/journal.pone.0189044] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
3 Kohli DR, Samadder NJ, DiSario JA. Chromoendoscopy: adding color to duodenal polyps. Gastrointest Endosc 2018;88:674-5. [PMID: 30217241 DOI: 10.1016/j.gie.2018.06.013] [Reference Citation Analysis]
4 Neuhann TM, Haub K, Steinke-lange V, Morak M, Laner A, Locher M, Holinski-feder E. Long-term chemoprevention in patients with adenomatous polyposis coli: an observational study. Familial Cancer. [DOI: 10.1007/s10689-022-00292-2] [Reference Citation Analysis]
5 Li QZ, Zuo ZW, Zhou ZR, Ji Y. Polyamine homeostasis-based strategies for cancer: The role of combination regimens. Eur J Pharmacol 2021;910:174456. [PMID: 34464603 DOI: 10.1016/j.ejphar.2021.174456] [Reference Citation Analysis]
6 Tripathi SC, Fahrmann JF, Vykoukal JV, Dennison JB, Hanash SM. Targeting metabolic vulnerabilities of cancer: Small molecule inhibitors in clinic. Cancer Rep (Hoboken) 2019;2:e1131. [PMID: 32721114 DOI: 10.1002/cnr2.1131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
7 Hall MJ. Updates in chemoprevention research for hereditary gastrointestinal and polyposis syndromes. Curr Treat Options Gastroenterol 2021;19:30-46. [PMID: 34211259 DOI: 10.1007/s11938-020-00306-x] [Reference Citation Analysis]
8 Ramos-Inza S, Ruberte AC, Sanmartín C, Sharma AK, Plano D. NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future. J Med Chem 2021;64:16380-421. [PMID: 34784195 DOI: 10.1021/acs.jmedchem.1c01460] [Reference Citation Analysis]
9 Laukaitis CM, Erdman SH, Gerner EW. Chemoprevention in patients with genetic risk of colorectal cancers. Colorectal Cancer 2012;1:225-40. [PMID: 25221625 DOI: 10.2217/crc.12.22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
10 Gutiérrez LG, Hernández-Morales M, Núñez L, Villalobos C. Inhibition of Polyamine Biosynthesis Reverses Ca2+ Channel Remodeling in Colon Cancer Cells. Cancers (Basel) 2019;11:E83. [PMID: 30642111 DOI: 10.3390/cancers11010083] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
11 Villalobos C, Hernández-morales M, Gutiérrez LG, Núñez L. TRPC1 and ORAI1 channels in colon cancer. Cell Calcium 2019;81:59-66. [DOI: 10.1016/j.ceca.2019.06.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
12 Tajada S, Villalobos C. Calcium Permeable Channels in Cancer Hallmarks. Front Pharmacol 2020;11:968. [PMID: 32733237 DOI: 10.3389/fphar.2020.00968] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
13 Gobert AP, Boutaud O, Asim M, Zagol-Ikapitte IA, Delgado AG, Latour YL, Finley JL, Singh K, Verriere TG, Allaman MM, Barry DP, McNamara KM, Sierra JC, Amarnath V, Tantawy MN, Bimczok D, Piazuelo MB, Washington MK, Zhao S, Coburn LA, Wilson KT. Dicarbonyl Electrophiles Mediate Inflammation-Induced Gastrointestinal Carcinogenesis. Gastroenterology 2021;160:1256-1268.e9. [PMID: 33189701 DOI: 10.1053/j.gastro.2020.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Katona BW, Weiss JM. Chemoprevention of Colorectal Cancer. Gastroenterology 2020;158:368-88. [PMID: 31563626 DOI: 10.1053/j.gastro.2019.06.047] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
15 Clapper ML, Chang WL, Cooper HS. Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention. Cancer Prev Res (Phila) 2020;13:229-40. [PMID: 32132117 DOI: 10.1158/1940-6207.CAPR-19-0316] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
16 LoGiudice N, Le L, Abuan I, Leizorek Y, Roberts SC. Alpha-Difluoromethylornithine, an Irreversible Inhibitor of Polyamine Biosynthesis, as a Therapeutic Strategy against Hyperproliferative and Infectious Diseases. Med Sci (Basel) 2018;6:E12. [PMID: 29419804 DOI: 10.3390/medsci6010012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
17 Gerner EW, Bruckheimer E, Cohen A. Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer. J Biol Chem. 2018;293:18770-18778. [PMID: 30355737 DOI: 10.1074/jbc.tm118.003343] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
18 Lewandowska P, Szczuka I, Bednarz-Misa I, Szczęśniak-Sięga BM, Neubauer K, Mierzchała-Pasierb M, Zawadzki M, Witkiewicz W, Krzystek-Korpacka M. Modulating Properties of Piroxicam, Meloxicam and Oxicam Analogues against Macrophage-Associated Chemokines in Colorectal Cancer. Molecules 2021;26:7375. [PMID: 34885960 DOI: 10.3390/molecules26237375] [Reference Citation Analysis]
19 Lewandowska P, Wierzbicki J, Zawadzki M, Agrawal A, Krzystek-Korpacka M. Biphasic Expression of Atypical Chemokine Receptor (ACKR) 2 and ACKR4 in Colorectal Neoplasms in Association with Histopathological Findings. Biomolecules 2020;11:E8. [PMID: 33374792 DOI: 10.3390/biom11010008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Mohammed A, Yarla NS, Madka V, Rao CV. Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives. Int J Mol Sci 2018;19:E2332. [PMID: 30096840 DOI: 10.3390/ijms19082332] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
21 Krzystek-Korpacka M, Szczęśniak-Sięga B, Szczuka I, Fortuna P, Zawadzki M, Kubiak A, Mierzchała-Pasierb M, Fleszar MG, Lewandowski Ł, Serek P, Jamrozik N, Neubauer K, Wiśniewski J, Kempiński R, Witkiewicz W, Bednarz-Misa I. L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs. Cancers (Basel) 2020;12:E2594. [PMID: 32932854 DOI: 10.3390/cancers12092594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
22 Singh A, Steinhagen E, Katona BW. Approach to upper gastrointestinal tract lesions in familial adenomatous polyposis. Seminars in Colon and Rectal Surgery 2018;29:102-7. [DOI: 10.1053/j.scrs.2018.06.003] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
23 Damiani E, Wallace HM. Polyamines and Cancer. Methods Mol Biol 2018;1694:469-88. [PMID: 29080189 DOI: 10.1007/978-1-4939-7398-9_39] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
24 Takeshita E, Enomoto T, Saida Y. Alternative treatments for prophylaxis of colorectal cancer in familial adenomatous polyposis. J Anus Rectum Colon 2017;1:74-7. [PMID: 31583304 DOI: 10.23922/jarc.2017-007] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]